Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer

results of a markov chain model

C Uyl-De Groot, Joseph Mcdonnell, G Velde, D Radice, H Groen

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)317-323
Number of pages7
JournalTherapeutics and Clinical Risk Management
Volume2
Issue number3
Publication statusPublished - 2006

Cite this

@article{382fecbf61f442c585fa557f43e56973,
title = "Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain model",
author = "{Uyl-De Groot}, C and Joseph Mcdonnell and G Velde and D Radice and H Groen",
year = "2006",
language = "English",
volume = "2",
pages = "317--323",
journal = "Therapeutics and Clinical Risk Management",
issn = "1176-6336",
publisher = "Global Science Books",
number = "3",

}

Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer : results of a markov chain model. / Uyl-De Groot, C; Mcdonnell, Joseph; Velde, G; Radice, D; Groen, H.

In: Therapeutics and Clinical Risk Management, Vol. 2, No. 3, 2006, p. 317-323.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer

T2 - results of a markov chain model

AU - Uyl-De Groot, C

AU - Mcdonnell, Joseph

AU - Velde, G

AU - Radice, D

AU - Groen, H

PY - 2006

Y1 - 2006

M3 - Article

VL - 2

SP - 317

EP - 323

JO - Therapeutics and Clinical Risk Management

JF - Therapeutics and Clinical Risk Management

SN - 1176-6336

IS - 3

ER -